MedTrace Logo

Changes in Corneal Endothelial Cell Density After Transscleral ab Interno Glaucoma Gel Stent Implantation

NCT04547036 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2021-07-13

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the change of endothelial cell count after XEN45 in patients with or without cataract operation.

Conditions

  • Glaucoma
  • Endothelial Cell Loss, Corneal

Interventions

DEVICE

XEN45

Up to 140 consecutive patients with preoperatively recorded endothelial cell counts will be summoned to a consecutive endothelial cell count record and measurement of central corneal thickness postoperatively.

Sponsors & Collaborators

  • Paracelsus Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-30
Primary Completion
2021-01-31
Completion
2021-04-30
FDA Device
Yes

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04547036 on ClinicalTrials.gov